Program Committee

Program Committee Co-Chairs:

Zoltan Kalo, PhD
Professor of Health Economics, Eötvös Loránd University (ELTE), Chief Executive Officer, Syreon Research Institute
Hungary

Guillem López-Casasnovas, PhD
Professor, Department of Economics and Founder & Director, Center for Health and Economics, Universitat Pompeu Fabra
Spain

Sarah Garner, PhD
Coordinator, Innovation, Access and Use, Essential Medicines and Health Products Department, World Health Organization (WHO)
Switzerland

Research Committee Co-Chairs:

Andrea Manca, MSc, PhD
Professor, Centre for Health Economics, University of York
United Kingdom

Margreet G. Franken, PhD
Assistant Professor
Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University
The Netherlands

Murtuza Bharmal, PhD
Head,Oncology Brands & Life Cycle Management, Global Evidence & Value Development, Global Research & Development Merck KGaA, Frankfurter
Germany

Robert Hettle, MMAth
Director, Health Economics and Payer Evidence, AstraZeneca
UK

Issue Panel Review Committee Co-Chairs:

René Allard, PhD
Public Disclosure Lead, Grünenthal GmbH
Germany

Luciana Ballini, BSc, MSc
Senior Researcher, Azienda USL-IRCCS Reggio Emilia, Regional Agency for Health (ASSR)
Italy

Jamie O'Hara
Chief Executive Officer, HCD Economics, MASAG Committee Member, European Haemophilia Consortium (EHC), Brussels, Belgium, Trustee UK Haemophilia Society, Macfarlane Trust, Metabolic Disorders UK, Senior Lecturer, Health Economics, University of Chester
Belgium

Workshop Review Committee Co-Chairs:

Paul O'Donohoe, MS, BS
Scientific Lead, eCOA and Mobile Health, Medidata Solutions
UK

Carme Pinyol, MD, PhD, MSc
Head, Pricing and Market Access Southern Europe, Pierre Fabre and President ISPOR Spain Chapter
Spain

Martin Scott MSc
Director & Statistician
Numerus Ltd.
Germany